Navan, Inc. NAVN 深 沪
交易中 12-18 10:59:36 美东时间
13.595
+0.695
+5.39%
华盛通- 最 高13.70
- 今 开13.00
- 成交量 46.41万股
- 最 低 12.81
- 昨 收 12.90
- 总市值 33.72亿
- 52周最高 22.75
- 市盈率 静 --
- 换手率 0.19%
- 52周最低 11.76
- 委 比 -4.72%
- 总股本 2.48亿
- 历史最高 22.75
- 量 比 0.87
- 振 幅 6.90%
- 历史最低 11.76
- 每 手 1
- 风险率 2.39%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多期权扫描 | 特斯拉股价创新高！大量资金通过看涨期权布局做多机会；辉瑞看跌期权成交占比近50%
特斯拉股价创新高！大量资金通过看涨期权布局做多机会；辉瑞预计2026年营收增长将放缓！看跌期权成交占比近50%，一PUT单大涨近100%>>
12-17 17:55
What's Going On With Navan Stock Tuesday?
Navan, Inc. (NASDAQ:NAVN) shares are trading lower Tuesday. The company reported third-quarter financial results.
12-17 00:22
Navan shares are trading lower. The company reported Q3 financial results.
Navan shares are trading lower. The company reported Q3 financial results.
12-16 05:38
Navan Sees Q4 Sales $161.000M-$163.000M
Navan (NASDAQ:NAVN) sees Q4 sales of $161.000 million-$163.000 million.
12-16 05:10
Navan Sees FY2026 Sales $685.000M-$687.000M vs $830.874M Est
Navan (NASDAQ:NAVN) sees FY2026 sales of $685.000 million-$687.000 million vs $830.874 million analyst estimate.
12-16 05:10
Navan Q3 EPS $0.19 Beats $(0.50) Estimate, Sales $194.934M Beat $182.041M Estimate
Navan (NASDAQ:NAVN) reported quarterly earnings of $0.19 per share which beat the analyst consensus estimate of $(0.50) by 137.85 percent. This is a 161.29 percent increase over losses of $(0.31) per share from the same
12-16 05:07
Top Stocks With Earnings This Week: Micron, FuelCell, Carnival and More
Investors are prepping for this week's earnings reports which include homebuilders, several apparel companies and a big tech company.
12-15 23:54
Earnings Scheduled For December 15, 2025
Companies Reporting Before The Bell • MindWalk Holdings (NASDAQ:HYFT) is likely...
12-15 19:11
Argenx, Navan And 3 Stocks To Watch Heading Into Monday
Stock futures up, focus on HYFT, ARGX, NAVN, AXR, CSBR as they report earnings. Top 2 energy stocks to watch for potential plunge this month.
12-15 15:42
美股大行评级 | 博通、Lululemon获10逾家大行上调目标价；好市多、RH遭大行下调目标价
今日重点评级关注：杰富瑞：维持ImmunityBio Inc Ordinary Shares"买入"评级，目标价从8美元升至9美元；B. Riley证券：维持WAVE Life Sciences"买入"评级，目标价从19美元升至37美元
12-15 15:30
